ELTIPIC Trademark

Trademark Overview

On Monday, September 13, 2010, a trademark application was filed for ELTIPIC with the United States Patent and Trademark Office. The USPTO has given the ELTIPIC trademark a serial number of 85127904. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 2, 2014. This trademark is owned by Glaxo Group Limited. The ELTIPIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
eltipic

General Information

Serial Number85127904
Word MarkELTIPIC
Filing DateMonday, September 13, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 2, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ELTIPIC" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 16, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, June 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 2, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2013EXTENSION 5 GRANTED
Monday, October 21, 2013EXTENSION 5 FILED
Monday, October 21, 2013TEAS EXTENSION RECEIVED
Tuesday, April 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2013EXTENSION 4 GRANTED
Tuesday, April 9, 2013EXTENSION 4 FILED
Tuesday, April 9, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 12, 2012EXTENSION 3 GRANTED
Wednesday, October 10, 2012EXTENSION 3 FILED
Wednesday, October 10, 2012TEAS EXTENSION RECEIVED
Thursday, May 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 2, 2012EXTENSION 2 GRANTED
Wednesday, April 4, 2012EXTENSION 2 FILED
Wednesday, May 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Friday, October 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2011EXTENSION 1 GRANTED
Wednesday, October 12, 2011EXTENSION 1 FILED
Wednesday, October 12, 2011TEAS EXTENSION RECEIVED
Tuesday, April 26, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2011PUBLISHED FOR OPPOSITION
Friday, January 21, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 21, 2011ASSIGNED TO LIE
Tuesday, December 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 20, 2010ASSIGNED TO EXAMINER
Thursday, September 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 16, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

eltipic pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological